Importantly, previous studies have shown that CBD (5 mg/kg) inhibits the growth of MDA-MB-231 breast cancer cells in vivo using xenograft mouse models [13], once again highlighting a potential role for CBD in the treatment of GPR55 overexpression and aggressive cancer types. This evidence concerns the gene GPR55 and breast cancer.